Hosted on MSN9h
AEMD Treats First Patient in Australian Safety, Feasibility & Dose-Finding Clinical Trial of HemopurifierAEMD Aethlon Medical (NASDAQ:AEMD) announced that the first patient in its Australian safety, feasibility and dose-finding ...
"Aethlon Medical treats first subject with Hemopurifier device in Australia" was originally created and published by Medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback